Abstract: The present invention relates to a purified polypeptide comprising or consisting of a C-terminus Merozoite Surface Protein 1 (MSP1) antigen from Plasmodium falciparum carrying a Glycosyl-phosphatidyl-inositol group (GPI), an immunogenic composition and a vaccine against a Plasmodium infection comprising said purified polypeptide.
Type:
Grant
Filed:
January 12, 2007
Date of Patent:
May 29, 2012
Assignee:
Institut Pasteur
Inventors:
Shirley Longacre, Sarah Bonnet, Thierry Fontaine, Charles Roth, Faridabano Nato